Celularity, Inc. (CELU)
1.82
-0.03
(-1.62%)
USD |
NASDAQ |
Sep 01, 16:00
1.84
+0.02
(+1.10%)
After-Hours: 19:49
Celularity Total Long Term Debt (Quarterly) : 60.71M for Dec. 31, 2025
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 60.71M |
| September 30, 2025 | 62.48M |
| June 30, 2025 | 63.21M |
| March 31, 2025 | 63.12M |
| December 31, 2024 | 62.48M |
| September 30, 2024 | 26.45M |
| June 30, 2024 | 26.36M |
| March 31, 2024 | 26.26M |
| December 31, 2023 | 26.18M |
| September 30, 2023 | 26.07M |
| June 30, 2023 | 45.13M |
| March 31, 2023 | 32.79M |
| December 31, 2022 | 27.98M |
| September 30, 2022 | 27.92M |
| Date | Value |
|---|---|
| June 30, 2022 | 27.85M |
| March 31, 2022 | 30.46M |
| December 31, 2021 | 31.14M |
| September 30, 2021 | 31.07M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 30.93M |
| December 31, 2020 | 30.64M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 0.00 |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | 0.00 |
| Century Therapeutics, Inc. | 34.63M |
| Absci Corp. | 1.792M |